https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
Previous meta-analyses suggested that treating hospital-acquired pneumonia (HAP), including ventilator-associated pneumonia (VAP), with empiric carbapenems was associated with lower mortality rates but higher rates of clinical failure for pseudomonal pneumonia. This study was an updated meta-analysis with sensitivity analyses and meta-regression to better understand the impact of carbapenem use in HAP/VAP. What is the efficacy of carbapenems for empiric treatment of nosocomial pneumonia? Databases were searched for randomize
Like
Comment
Share
